Bayzed Health Group (HKSE:02609) ROCE %: 3.23% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02609 Bayzed Health Group Inc HKSE:02609
12 GF Score
Price HK$2.99
! 2 Warning Signs
View Full Analysis

What is Bayzed Health Group ROCE %?

Bayzed Health Group HKSE:02609 -1.81% 12 ROCE % is 3.23% as of Dec. 2025. GuruFocus rates HKSE:02609 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bayzed Health Group's annualized ROCE % for the quarter that ended in Dec. 2025 was 3.23%.

Bayzed Health Group  (HKSE:02609) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bayzed Health Group ROCE % Related Terms

Bayzed Health Group ROCE % Historical Data

* Premium members only.

The historical data trend for Bayzed Health Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayzed Health Group ROCE % Chart

Bayzed Health Group Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
-2.40 -2.67 1.53 2.37 1.90

Bayzed Health Group Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial 1.80 1.63 3.19 0.05 3.23
HKSE:02609
12GF Score
Bayzed Health Group Inc HKSE:02609
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayzed Health Group ROCE % Calculation

Bayzed Health Group's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=34.05/( ( (2352.173 - 834.677) + (2823.819 - 761.039) )/ 2 )
=34.05/( (1517.496+2062.78)/ 2 )
=34.05/1790.138
=1.90 %

Bayzed Health Group's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=67.13/( ( (2910.341 - 818.677) + (2823.819 - 761.039) )/ 2 )
=67.13/( ( 2091.664 + 2062.78 )/ 2 )
=67.13/2077.222
=3.23 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 3.23% mean?
Bayzed Health Group (HKSE:02609) has a ROCE % of 3.23% as of Dec. 2025.
Is Bayzed Health Group's ROCE % too high?
Bayzed Health Group's current ROCE % is 3.23%. The Healthcare Providers & Services industry median ROCE % is 6.64. Bayzed Health Group's value of 3.23% is 51.3% below this industry median. Overall, Bayzed Health Group has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bayzed Health Group's ROCE % compare to HCA and THC?
Bayzed Health Group's ROCE % of 3.23% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.64. Bayzed Health Group's value of 3.23% is 51.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.64, based on 642 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bayzed Health Group's current ROCE % of 3.23% is 51.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bayzed Health Group's current ROCE % is 3.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayzed Health Group stock overvalued right now?
Bayzed Health Group (HKSE:02609) has a current ROCE % of 3.23%. The current ROCE % is 3.23% and 51.3% below the Healthcare Providers & Services industry median of 6.64. Bayzed Health Group's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Bayzed Health Group (HKSE:02609), the current ROCE % is 3.23% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bayzed Health Group Business Description

Address No. 16 Lize Road, Room 2401, Mingfeng Tower Office Building, Fengtai District, Beijing, CHN
Bayzed Health Group Inc is an oncology healthcare group that principally engages in the investment in, and provision of, medical and healthcare related services in the PRC. It operates and manages a network of eight hospitals in Beijing, Tianjin, Shanxi Province, Anhui Province, and Henan Province, with a strategic focus on the provision of full-cycle oncology healthcare services through its direct ownership of the equity interest in six private for-profit hospitals and management over two private not-for-profit hospitals.
12GF Score

Get the complete analysis for HKSE:02609

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.99
Price